Enabling drug release from medical devices
PolyActiva Pty Ltd uses a unique drug-polymer conjugate technology to enable site specific drug delivery from medical device components, such as implants, films, or fibers.
**Press release: PolyActiva completes recruitment in key Phase I glaucoma implant safety study. Six-month treatment period demonstrated…read more…
The PolyActiva product portfolio is composed of market validated products at different stages of development and with different risk / reward profiles.
Preventive & Treatment Implants:
Sustained Drug Release & Fully Biodegradable
PolyActiva has developed a platform technology that enables the slow release, site-specific drug delivery directly to the site of action.